#FutureReadyHealthcare
Share this blog
28 Jan 2025
The way life sciences companies approach their digital presence is set to change dramatically in 2025. Web solutions are no longer just tools—they’re becoming strategic assets driving patient and HCP centric innovation and operational excellence.
With customer expectations at an all-time high and technology advancing at breakneck speed, the industry is set to move toward transformative trends that will redefine how companies connect, communicate, and deliver value. From AI-powered content management systems to bold design paradigms like anti-design — this year will be pivotal for organizations looking to stay ahead of the curve. But what will these changes look like in practice? And how can organizations adapt to stay ahead?
Let’s explore five key digital healthcare market trends that will redefine web solutions for the life sciences industry to help you make sense of what’s coming next.
1. Generative AI in CMS: From Experimentation to Implementation
Generative AI (GenAI) is transforming how life sciences companies approach content management. Once confined to experimental projects, GenAI is now becoming a standard feature in CMS platforms. By automating key processes such as content creation, translation, and compliance checks, GenAI enhances both the efficiency and scalability of CMS platforms.
According to EY, 79% of life sciences CIOs expect to allocate 5% to 25% of their tech budget toward GenAI spend for the next two years. This will drive significant innovations in products and processes, including AI-powered CMS platforms.
Key Insight: For life sciences organizations, adopting GenAI in CMS offers a significant opportunity to improve patient engagement by creating hyper-personalized, multilingual content. However, they must ensure the technology aligns with industry-specific regulations and best practices, such as ensuring accuracy in medical content and maintaining security standards to protect patient data to deliver a more dynamic and responsive digital experience for their audiences.
2. Cloud and Containerized Platforms: Scalable Digital Infrastructure
Many life sciences companies still rely on on-premises or private cloud solutions, which are often rigid and expensive. Cloud-native and containerized models are emerging as the answer, offering scalability, cost efficiency, and faster deployment for digital infrastructure.
According to Business Research Insights, the global market for Cloud Native Platforms and Container Management Platforms is valued at USD 7.51 billion in 2024, with projections to reach USD 46.52 billion by 2032, growing at a compound annual growth rate (CAGR) of 25.61%.
Key insight: As the adoption of cloud-native and containerized models accelerates, life sciences companies must also consider key factors for success. One crucial aspect is ensuring compliance readiness, particularly when it comes to industry regulations, data security, and migration strategies. Establishing partnerships with industry experts is essential to ensure that solutions meet evolving standards. By leveraging advanced platforms, life sciences companies can not only reduce costs and improve scalability but also create patient-centric digital experiences aligned with regulatory requirements.
3. Enterprise Design Systems: Scaling Creativity and Consistency
Design Systems (DS) provide a centralized framework for branding, design, and user experience, enabling organizations to create consistent and scalable digital products. Precision and compliance are non-negotiables in life sciences; hence, the adoption of DS is quickly gaining traction. These systems are helping teams optimize complex workflows and maintain a cohesive digital presence.
Key Insight: Organizations must approach this trend strategically. It’s vital to ensure that the DS aligns with regulatory standards unique to the life sciences sector while being flexible enough to accommodate diverse digital needs. Investing in training for teams, promoting collaboration across departments, and forming strategic partnerships will be key to maximizing the benefits of a DS.
4. Hybrid CMS Models: Balancing Innovation and Stability
Life sciences organizations traditionally rely on monolithic CMS platforms for their centralized content needs. However, the rise of headless CMS, which separates content management from delivery, is currently driving interest in hybrid CMS models. These solutions combine the strengths of both approaches, offering flexibility for multi-channel delivery without sacrificing stability.
According to Adobe Experience Cloud, Hybrid CMS models can increase the amount of content delivered by web admin teams by 78%. This increased efficiency enables teams to deliver faster and consistent content across multiple platforms, making it easier to meet the growing demands of digital engagement.
Key insight: Hybrid CMS models drive operational efficiency and support compliance in life sciences by enabling faster, consistent content delivery across multiple channels. To capitalize on these benefits, life sciences organizations must select platforms that meet strict regulatory and security standards. Additionally, partnering with advisory experts will ensure proper integration and successful adoption in the long-term.
5. Experimenting with Anti-Design: Rethinking Digital Experiences
Historically conservative in their digital strategies, life sciences organizations are starting to tap into anti-design—a bold approach that deliberately challenges traditional design conventions. This trend prioritizes attention-grabbing visuals and unconventional layouts to better connect with today’s digitally savvy audiences.
More than just a visual statement, anti-design in life sciences serves a deeper purpose: to humanize digital platforms and make complex information more digestible. Organizations can forge stronger connections with patients and HCPs, while breaking free from the rigidity of traditional UX patterns.
According to Salesforce, almost 90% of customers believe that a company’s customer experience is just as important as its products or services. With patients and healthcare professionals expecting more dynamic and engaging experiences, life sciences firms are increasingly experimenting with CX and UX design in healthcare with anti-design patterns.
Key insight: By embracing anti-design, life sciences organizations can create more engaging and memorable user experiences that resonate with modern expectations. However, they must balance creativity with functionality, ensuring accessibility and compliance remain intact. As they explore this trend, prioritizing user testing will be crucial to evaluate the effectiveness of unconventional design elements and refine them to meet audience needs.
A Patient-Centric Blueprint for the Future
The digital health trends shaping 2025 highlight the life sciences industry's unwavering focus on leveraging digital innovation to improve patient outcomes. From AI-powered solutions that streamline content creation to bold UX design approaches that challenge traditional norms, these changes are more than technological upgrades—they’re are reimagining how organizations connect with patients and healthcare professionals.
By engaging with these trends, life sciences companies can create digital experiences that are not only efficient but also deeply engaging and patient centered.
The result? Stronger relationships with patients, more agile operations, and a significant edge in an increasingly competitive landscape.
Share this blog
Get exclusive pharma
insights delivered to your inbox
Latest
Latest
